-transparent.png){kind=logo}
Xanthomonas maltophilia is a potentially pathogenic organism with a broad clinical spectrum. Nosocomial colonization and infection are the most common manifestations. The incidence of clinical isolation of X. maltophilia is on the rise, possibly in part because of the selective pressure from the new antimicrobial agents to which it is resistant. The organism is usually resistant to commonly used antimicrobial agents, including most cephalosporins, aztreonam, antipseudomonal penicillins, imipenem, and the quinolones.
Related Publications
W F Marshall, and
M R Keating, and
J P Anhalt, and
J M Steckelberg
January 1997,
Pharmacotherapy,
W F Marshall, and
M R Keating, and
J P Anhalt, and
J M Steckelberg
April 1998,
International journal of STD & AIDS,
W F Marshall, and
M R Keating, and
J P Anhalt, and
J M Steckelberg
December 1992,
Medicina clinica,
W F Marshall, and
M R Keating, and
J P Anhalt, and
J M Steckelberg
October 1993,
Medicina clinica,
W F Marshall, and
M R Keating, and
J P Anhalt, and
J M Steckelberg
January 2006,
Enfermedades infecciosas y microbiologia clinica,
W F Marshall, and
M R Keating, and
J P Anhalt, and
J M Steckelberg
April 1988,
The Journal of hospital infection,
W F Marshall, and
M R Keating, and
J P Anhalt, and
J M Steckelberg
May 2009,
The Lancet. Infectious diseases,
W F Marshall, and
M R Keating, and
J P Anhalt, and
J M Steckelberg
January 2012,
Clinical microbiology reviews,
W F Marshall, and
M R Keating, and
J P Anhalt, and
J M Steckelberg
February 1995,
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
W F Marshall, and
M R Keating, and
J P Anhalt, and
J M Steckelberg
July 2004,
The new microbiologica,
